SCHEMBL4095237

SCHEMBL4095237

[2H]C([2H])(Oc1ccc2c(c1)OCO2)[C@@H]1CN(C(=O)Oc2ccccc2)CC[C@H]1c1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.51
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
CYP3A4 P08684 4/20 0.47
HTR1A P08908 4/20 0.47
TP53 P04637 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
GRK2 P25098 2/20 0.47
CHRM2 P08172 2/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP2C9 P11712 1/20 0.47
HSD17B10 Q99714 1/20 0.47
NPC1 O15118 1/20 0.47
CACNA1F O60840 1/20 0.47
MPO P05164 1/20 0.47
ADRB2 P07550 1/20 0.47
CHRM4 P08173 1/20 0.47
ABCB1 P08183 1/20 0.47
CHRM5 P08912 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15663054 1.00 L3MBTL1 (0.51) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL13799658 0.94 L3MBTL1 (0.44) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL14608906 0.92 L3MBTL1 (0.61) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL7466131 0.92 L3MBTL1 (0.61) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL5323659 0.92 L3MBTL1 (0.61) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL13799675 0.87 L3MBTL1 (0.53) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL3054659 0.84 MGLL (0.52) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL7455728 0.84 MGLL (0.47) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL4426374 0.83 L3MBTL1 (0.58) L3MBTL1MEN1KMT2ACYP3A4HTR1A
SCHEMBL6693166 0.83 L3MBTL1 (0.58) L3MBTL1MEN1KMT2ACYP3A4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315483-B2 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof CONCERT PHARMACEUTICALS, INC. (US) 2016-04-19 US disclosed
EP-2727915-B1 Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof CONCERT PHARMACEUTICALS INC (US) 2016-04-13 EP disclosed
EP-2200997-B9 Synthesis of deuterated benzodioxoles CONCERT PHARMACEUTICALS INC (US) 2016-01-13 EP disclosed
US-20140336387-A1 SYNTHESIS OF DEUTERATED CATECHOLS AND BENZO[D][1,3]DIOXOLES AND DERIVATIVES THEREOF CONCERT PHARMACEUTICALS, INC. (US) 2014-11-13 US disclosed
US-8822498-B2 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof CONCERT PHARMACEUTICALS, INC. (US) 2014-09-02 US disclosed
EP-2200997-B1 Synthesis of deuterated benzodioxoles CONCERT PHARMACEUTICALS INC (US) 2013-11-06 EP disclosed
US-20090143432-A1 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof CONCERT PHARMACEUTICALS, INC. (US) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336387-A1 SYNTHESIS OF DEUTERATED CATECHOLS AND BENZO[D][1,3]DIOXOLES AND DERIVATIVES THEREOF COMT, DRD2, DRD3 L3MBTL1 3072/4885MEN1 2179/4885KMT2A 845/4885
US-20090143432-A1 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof COMT, DRD2, DRD3 L3MBTL1 3072/4885MEN1 2179/4885KMT2A 845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.